WPI 3720 (Tranexamic Acid 650 mg)
Pill with imprint WPI 3720 is White, Elliptical/Oval and has been identified as Tranexamic Acid 650 mg. It is supplied by Watson Laboratories, Inc.
Tranexamic acid is used in the treatment of menstrual disorders; menorrhagia; bleeding disorder; factor ix deficiency; hemophilia a and belongs to the drug class miscellaneous coagulation modifiers. There is no proven risk in humans during pregnancy. Tranexamic acid 650 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 3720
- WPI 3720
- 650 mg
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00591-3720||Watson Pharmaceuticals, Inc.|
|68084-0929 (Discontinued)||Amerisource Health Services|
More about tranexamic acid
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (252)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: miscellaneous coagulation modifiers
- Drug Information
- Tranexamic acid (Advanced Reading)
- Tranexamic acid Intravenous (Advanced Reading)
- Tranexamic Acid Tablets
- Tranexamic Acid Injection
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.